Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Konica Minolta ( (JP:4902) ) just unveiled an announcement.
Konica Minolta has recorded significant financial impacts due to strategic divestments and operational challenges. During the quarter ending December 2024, it reported a profit from the sale of Ambry Genetics, marking its exit from the precision medicine business, while facing impairment losses in its Industry Business segment due to intensified competition and changes in customer investment behaviors.
More about Konica Minolta
Konica Minolta, Inc. operates in the technology industry, focusing on imaging, precision medicine, and industrial businesses. Its primary products include office equipment, medical systems, and industrial optical systems, with a significant market focus on innovation and enhancing operational efficiency.
YTD Price Performance: -6.37%
Average Trading Volume: 2,278
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $1.94B
See more data about 4902 stock on TipRanks’ Stock Analysis page.
